about
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies.Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sedimentsEnhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TBCatching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaThe Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant TuberculosisUse of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in IndiaFactors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective AnalysisRapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyContainment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in IndiaXpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority studyAnalytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis.Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosisEarly depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection.Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platformAn Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".Tuberculosis Diagnostics in the New Millennium: Role in TB Identification and Control.Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.Aiming for zero tuberculosis transmission in low-burden countries."Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.Importance of diagnostics in epidemic and pandemic preparednessCost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
P50
Q26765026-D97C6C30-9350-4E87-ADDD-C1C39311BC71Q28485224-C212C9D8-0347-474B-B6B7-A3B24E31F6F7Q28542451-BDFC9A18-B8EA-43A3-ADA1-B45817951A90Q28543236-6B4B7A6D-4176-4925-9506-86704A1ACA6EQ28546035-8E0E9AB8-57A0-475F-BF9F-2552155AB188Q28547389-05D77901-4FD1-4433-A3E4-EAD6FF680309Q28550398-8BFD5BB2-2FB5-4313-818B-4F567A266DA6Q33614228-8A1B689A-66E6-4A65-81C7-97FFE66866C5Q33663182-8847D3ED-82BE-4B56-9C02-5C5141041735Q33954547-ECD0C06A-D6BF-42A2-88A6-0D3608AD2E53Q35067040-C5DE531C-76CE-4BAA-A45E-2AA0FA8262F9Q35107029-24A7E4C1-ACB7-41DF-B005-771F886DB885Q35140095-EAB920C5-24B1-4F0D-8C6E-EBBF625EB2ECQ35808687-C42C72B9-1EDD-429E-83B2-B12DED8D987DQ36322028-E29A7DCA-4646-4D3F-89C1-84B1985FFBEAQ36734863-39CD63A4-AFC5-417B-829D-1BB370B2C08BQ36970981-B8017A91-0E90-4082-89EA-7F57F04C8068Q37115595-9D098483-A960-4B47-A9AC-86DDA45B514BQ37659918-75F5D576-8393-40F9-AB10-FCBA5CAE6173Q38986223-5BC405DF-2D77-4BA6-9725-5F5197152CC5Q42278733-568A3674-183D-4A1A-B37F-6D91295B9ACBQ42742061-3438D476-9376-4565-8119-077E8EDA8538Q50071702-76F20855-85E1-41BC-A287-46B577416EADQ52652191-A1919EF1-11C7-4122-84F5-A329B54171C0Q52671839-22C7D516-F48C-461D-99BB-FD795C5EFAAEQ52681375-E9C52283-CC2B-4961-AF2A-34E406462B37Q62485424-A65E4653-1D65-4E37-8A3D-742C26672854Q64097023-F69EEC96-6F0B-4958-916D-68B419701E04
P50
name
Catharina Boehme
@en
type
label
Catharina Boehme
@en
prefLabel
Catharina Boehme
@en